BlackRock, Inc. 13D and 13G filings for ACADIA Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 06:04 am Purchase | 2025-01-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 19,878,746 11.900% | 8,469,528 (+74.23%) | Filing |
| 2024-01-26 5:25 pm Purchase | 2023-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 11,409,218 6.900% | 1,150,480 (+11.21%) | Filing |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,258,738 6.300% | 198,426 (+1.97%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,060,312 6.300% | 2,302,466 (+29.68%) | Filing |